New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in ...

Announcing a new publication for Acta Materia Medica journal. Epithelial cell adhesion molecule (EpCAM) is a biomarker for ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the ...

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers ...

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in ...

Researchers at Mount Sinai have achieved a significant breakthrough in treating hepatocellular carcinoma (HCC), the most ...

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...